Department of Endocrinology, University of Milan, Via A. del Sarto 21, 20129 Milan, Italy
(Received 8 May 1978)
It is well established that the rat prostate gland converts testosterone mainly into 5α-androstan-17β-ol-3-one (5α-dihydrotestosterone, 5α-DHT) and to a lesser extent into 5α-androstan-3α,17β-diol (5α-tetrahydrotestosterone, 5α-THT). This occurs, both in vivo and in vitro, through the action of a 5α-reductase and a 3α-hydroxysteroid dehydrogenase system (Baulieu, Lasnitzki & Robel, 1968; Bruchovsky & Wilson, 1968; Gloyna & Wilson, 1969; Kniewald, Massa & Martini, 1971). It has also been recognized that, although the 5α-reduction of testosterone is an irreversible reaction, the reduction of 5α-DHT to 5α-THT is reversible (Becker, Grabosch, Hoffmann & Voigt, 1973; Cresti & Massa, 1977). Consequently, the question has been raised as to whether the biological actions of 5α-THT are attributable to the compound as such or to 5α-DHT. At the anterior pituitary level, 5α-reductase activity is increased by castration and decreased
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 1 | 0 | 0 |
PDF Downloads | 0 | 0 | 0 |